Announced Tue, 7 Jul · 19:15 IST
Compliance certificate under SEBI DP Regulations 74(5) for Q1 FY27
Compliance View source PDF
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.2%1-day move
₹440.00
prior close
₹437.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.7+0.1-0.8+0.2+2.6+1.9-0.8-1.4+1.0————
Up moveDown movePending
AI summary
Cohance Lifesciences (formerly Suven Pharmaceuticals) submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. Registrar KFin Technologies confirmed details of securities dematerialized and rematerialized during the period have been furnished to NSE and BSE. This is a routine procedural filing with no financial or business impact.
Likely market impact
Routine regulatory compliance filing, no material impact on shareholders or stock price.